SCHEMBL234592

SCHEMBL234592

N#Cc1ccc(Cl)c(F)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VCAM1 P19320 1/20 0.48
KIF11 P52732 1/20 0.39
AR P10275 2/20 0.39
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
CYP11B1 P15538 2/20 0.37
EGLN2 Q96KS0 3/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
S1PR4 O95977 1/20 0.37
S1PR1 P21453 1/20 0.37
S1PR3 Q99500 1/20 0.37
SLC22A12 Q96S37 1/20 0.37
TRPV4 Q9HBA0 1/20 0.37
ALDH1A1 P00352 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HTR2A P28223 2/20 0.36
KCNH2 Q12809 2/20 0.36
SLC6A4 P31645 1/20 0.36
CYP11B2 P19099 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30480935 1.00 VCAM1 (0.48) VCAM1KIF11ARMAOAMAOB
SCHEMBL233380 0.82 VCAM1 (0.44) VCAM1KIF11ARMAOAMAOB
SCHEMBL31195830 0.82 VCAM1 (0.44) VCAM1KIF11ARMAOAMAOB
SCHEMBL16136517 0.79 VCAM1 (0.50) VCAM1ARMAOAMAOBCA1
SCHEMBL29416796 0.78 EGLN2 (0.44) KIF11CYP11B1EGLN2CA2ALDH1A1
SCHEMBL229147 0.78 EGLN2 (0.44) KIF11CYP11B1EGLN2CA2ALDH1A1
SCHEMBL825866 0.78 VCAM1 (0.53) VCAM1ARMAOAMAOBCA1
SCHEMBL34471889 0.78 PSEN1 (0.48) VCAM1CYP11B1EGLN2S1PR4S1PR1
SCHEMBL12721370 0.77 IMPDH2 (0.39) KIF11CYP11B1EGLN2CA2ALDH1A1
SCHEMBL16955681 0.77 RAPGEF4 (0.34) SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119306598-A Catalyst composition, application thereof and synthetic method of cyhalofop-butyl 江苏省农用激素工程技术研究中心有限公司 2025-01-14 CN claimed
EP-0635486-B1 Process for the preparation of fluorobenzonitriles CLARIANT GMBH (DE) 1998-12-09 EP claimed
US-5466859-A Process for preparing fluorobenzonitriles HOECHST AKTIENGESELLSCHAFT (DE) 1995-11-14 US claimed
EP-0635486-A2 Process for the preparation of fluorobenzonitriles HOECHST AKTIENGESELLSCHAFT (DE) 1995-01-25 EP claimed
EP-3704096-B1 MODULATORS OF THE INTEGRATED STRESS PATHWAY CALICO LIFE SCIENCES LLC (US) 2026-04-22 EP disclosed
EP-4291183-B1 OXADIAZOLYL DIHYDROPYRANO[2,3-B]PYRIDINE INHIBITORS OF HIPK2 FOR TREATING KIDNEY FIBROSIS ICAHN SCHOOL MED MOUNT SINAI (US) 2026-04-08 EP disclosed
US-12570799-B2 Crystalline polyethernitrile TORAY INDUSTRIES, INC. (JP) 2026-03-10 US disclosed
CN-119306598-B Catalyst composition, application thereof and synthetic method of cyhalofop-butyl 江苏省农用激素工程技术研究中心有限公司 2025-12-12 CN disclosed
EP-4565589-A2 OXYGEN-CONTAINING HETEROCYCLIC COMPOUND AND USE THEREOF Icahn School of Medicine at Mount Sinai (US) 2025-06-11 EP disclosed
US-20250179084-A1 OXADIAZOLYL DIHYDROPYRANO[2,3-b]PYRIDINE INHIBITORS OF HIPK2 FOR TREATING KIDNEY FIBROSIS ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2025-06-05 US disclosed
US-20250145594-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ABBVIE INC. 2025-05-08 US disclosed
US-20250092208-A1 POLYETHER NITRILE FILM AND METHOD FOR PRODUCING POLYETHER NITRILE FILM TORAY INDUSTRIES, INC. (JP) 2025-03-20 US disclosed
EP-0635486-A2 Process for the preparation of fluorobenzonitriles HOECHST AKTIENGESELLSCHAFT (DE) 1995-01-25 EP disclosed
EP-0456793-A1 HALOPHENYL SUBSTITUTED HETEROCYCLIC DERIVATIVES. MERCK PATENT GMBH (DE) 1991-11-21 EP disclosed
WO-1991009016-A2 HALOPHENYL SUBSTITUTED HETEROCYCLIC DERIVATIVES MERCK PATENT GMBH (DE) 1991-06-27 WO disclosed
WO-1991009016-A1 HALOPHENYL SUBSTITUTED HETEROCYCLIC DERIVATIVES MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1991-06-27 WO disclosed
US-4704483-A FLUORINATION WITH POTASSIUM FLUORIDE OCCIDENTAL CHEMICAL CORPORATION (US) 1987-11-03 US disclosed
US-4582948-A VAPOR PHASE CHLORO-DENITRATION REACTION OCCIDENTAL CHEMICAL CORPORATION (US) 1986-04-15 US disclosed
EP-0159388-A2 Preparation of nuclear chlorinated compounds OCCIDENTAL CHEMICAL CORPORATION (US) 1985-10-30 EP disclosed
US-4470930-A Preparation of nuclear chlorinated aromatic compounds OCCIDENTAL CHEMICAL CORPORATION (US) 1984-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250145594-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ATF4, ATF1, DDIT3 VCAM1 4474/4885KIF11 3720/4885AR 2402/4885
US-12570799-B2 Crystalline polyethernitrile AR, NR5A1, ESRRA VCAM1 3399/4885KIF11 2556/4885AR 1/4885
US-20250179084-A1 OXADIAZOLYL DIHYDROPYRANO[2,3-b]PYRIDINE INHIBITORS OF HIPK2 FOR TREATING KIDNEY FIBROSIS HIPK2, HIPK3, HIPK1 VCAM1 3528/4885KIF11 3214/4885AR 330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.